Introduction Analytical Method Development and Impurity Profiling for complex cyclic peptide active pharmaceutical ingredients (APIs) establishes the analytical foundation necessary […]
Introduction Choosing an appropriate Good Manufacturing Practice (GMP) manufacturing partner for custom peptide synthesis services requires a detailed assessment of
Custom Peptide Synthesis Services: What to Look for in a GMP Manufacturing Partner Read More »
Introduction Achieving an efficient EU Generic Drug Dossier Development and EMA Submission through a Canadian Contract Development and Manufacturing Organization
Introduction: Peptide technology transfer to a CDMO is more than transferring a manufacturing recipe — it requires transfer of product,
Introduction Selecting the appropriate Generic Peptide Regulatory Pathway—whether an Abbreviated New Drug Application (ANDA) under Section 505(j), a hybrid New
What Regulatory Pathway Do Generic Peptide Drugs Follow — ANDA, 505(b)(2), or BLA? Read More »
Introduction A US-based cGMP peptide Contract Development and Manufacturing Organization (CDMO) provides comprehensive expertise in process chemistry, downstream purification, advanced
What Does a cGMP Peptide CDMO in the US Actually Offer? Read More »
Introduction Stability Testing for Generic Drug Products at a CDMO forms the scientific foundation for demonstrating that a generic finished
Introduction CMC documentation at a CDMO for ANDA submissions forms the foundation of regulatory compliance by demonstrating that a generic
CMC Documentation at a CDMO for ANDA: What Goes Into Sections P and S of the CTD Read More »
Introduction Radiolabeled Peptide Manufacturing involves a highly coordinated framework that combines automated solid-phase peptide synthesis, efficient chelator conjugation, and controlled
Case Study: Radiolabeled Peptide Manufacturing for a Diagnostic Imaging Program Read More »
Introduction Container Closure Integrity Testing (CCIT) for Generic Sterile Drug Products is a critical process used to confirm that a
